Skip to main content
Article thumbnail
Location of Repository

Loop B is a major structural component of the 5-HT3 receptor

By Andrew J. Thompson, Martin Lochner and S. C. R. Lummis


The 5-HT3 receptor belongs to a family of therapeutically important neurotransmitter-gated receptors whose ligand binding sites are formed by the convergence of six peptide loops (A-F). Here we have mutated 15 amino acid residues in and around loop B of the 5-HT3 receptor (Ser-177 to Asn-191) to Ala or a residue with similar chemical properties. Changes in [3H]granisetron binding affinity (Kd) and 5-HT EC50 were determined using receptors expressed in human embryonic kidney 293 cells. Substitutions at all but one residue (Thr-181) altered or eliminated binding for one or both mutants. Receptors were nonfunctional or EC50 values were altered for all but two mutants (S182T, I190L). Homology modeling indicates that loop B contributes two residues to a hydrophobic core that faces into the β-sandwich of the subunit, and the experimental data indicate that they are important for both the structure and the function of the receptor. The models also show that close to the apex of the loop (Ser-182 to Ile-190), loop B residues form an extensive network of hydrogen bonds, both with other loop B residues and with adjacent regions of the protein. Overall, the data suggest that loop B has a major role in maintaining the structure of the region by a series of noncovalent interactions that are easily disrupted by amino acid substitutions

Topics: QD
Publisher: Biophysical Society
Year: 2008
OAI identifier:

Suggested articles


  1. (2006). 5-HT3 receptors. doi
  2. (2005). A cation-p binding interaction with a tyrosine in the binding site of the GABAC receptor. doi
  3. (1984). A new force-field for molecular mechanical simulation of nucleic-acids and proteins. doi
  4. (2002). Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the alpha subunits. doi
  5. (1999). Antibodies against the extracellular domain of the 5-HT3 receptor label both native and recombinant receptors. Brain Res. doi
  6. (1988). Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA.
  7. (2002). Cation-p interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalousbindingpropertiesofnicotine.Biochemistry.41:10262–10269. doi
  8. (1993). Comparative protein modelling by satisfaction of spatial restraints. doi
  9. (2005). Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors. doi
  10. (2007). Crystal structure of the extracellular domain of nAChR a1 bound to a-bungarotoxin at 1.94 A ˚ resolution. doi
  11. (2005). FlexStation examination of 5-HT(3) receptor function using Ca 21- and membrane potential-sensitive dyes: advantages and potential problems. doi
  12. (1998). From ab initio quantum mechanics to molecular neurobiology: A cation-p binding site in the nicotinic receptor. doi
  13. (2005). Initial coupling of binding to gating mediated by conserved residues in the muscle nicotinic receptor. doi
  14. (2006). Interactions of granisetron with an agonist-free 5-HT3A receptor model. doi
  15. (2005). Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding. doi
  16. (2003). Membrane potential fluorescence: a rapid and highly sensitive assay for nicotinic receptor channel function. doi
  17. (2006). Mutagenesis and molecular modeling reveal the importance of the 5-HT3 receptor F-loop. doi
  18. (2004). Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. doi
  19. Prediction of 5-HT3 receptor agonist-binding residues using homology modeling. doi
  20. (1993). Radioligand binding methods: practical guide and tips. doi
  21. (1985). Rapid and efficient site-specific mutagenesis without phenotypic selection. doi
  22. (2005). Refined structure of the nicotinic acetylcholine receptor at 4A ˚ resolution. doi
  23. (2005). Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor. doi
  24. (2007). The 5-HT3 Receptor as a therapeutic target. Expert Opin. doi
  25. (2003). The role of loop 5 in acetylcholine receptor channel gating. doi
  26. (2000). The role of tryptophan residues in the 5-Hydroxytryptamine3 receptor ligand binding domain. doi
  27. (2004). The role of tyrosine residues in the extracellular domain of the 5-hydroxytryptamine3 receptor. doi
  28. (1996). Transfecting mammalian cells: optimization of critical parameters affecting calciumphosphate precipitate formation. Nucleic Acids Res. doi
  29. (2007). Unnatural amino acid mutagenesis of the GABAA receptor binding site residues reveals a novel cation-p interaction between GABA and b2 doi
  30. Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor. doi
  31. (2008). X-ray structure of a prokaryotic pentameric ligand-gated ion channel. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.